Supply Chain

Amgen, a biopharmaceutical company headquartered in Thousand Oaks, Calif., will lay off 200 research and development workers by the end of the year, according to STAT.

Genentech, a biologics drugmaker owned by Roche, will slash 130 jobs or about 13 percent of its workforce at its Vacaville, Calif. plant as the company faces increased biosimilar competition, according to STAT.

Valeant Pharmaceuticals International on Monday shared plans to sell the female libido business it purchased in 2015 back to its original owners for a fraction of the price, reports Bloomberg.

The Food and Drug Administration on Nov. 2 approved Valeant Pharmaceuticals International's eye drug Vyzulta.

CVS Health will offer next-day delivery for prescription drugs and other retail products at its 9,700 stores nationwide next year, according to USA Today.

Here are six drug and medical device companies that made headlines in the past week.

Woonsocket, R.I.-based CVS Health saw operating income decrease in the third quarter of fiscal year 2017 as its retail business faced reimbursement pressure and rising expenses related to recent hurricanes.

The Republican Tax Cuts and Jobs Act, unveiled in the House Thursday, would cut taxes by nearly $1.5 trillion over the next 10 years — impacting numerous taxpayers across the nation, including pharmaceutical companies, according to STAT.

Arriva Medical and American Medical Supplies, subsidiaries of Alere, are closing facilities in Florida, according to a Sun Sentinel report.

Senators introduced a bipartisan bill Tuesday calling on the Food and Drug Administration and CMS to create an action plan to reduce healthcare spending stemming from wasteful drug delivery practices.